SCHEMBL16893078

SCHEMBL16893078

Nc1ncc(-c2ccccc2)c(-c2c[nH]c(OC(=O)NCCc3cccnc3)c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 3/20 0.47
▸ NAMPT P43490 2/20 0.44
▸ ADORA1 P30542 3/20 0.42
▸ ADORA2A P29274 2/20 0.42
▸ MAPT P10636 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ EPHX1 P07099 1/20 0.41
▸ PTAFR P25105 2/20 0.41
▸ PTGFR P43088 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ AKT1 P31749 1/20 0.40
▸ AKT2 P31751 1/20 0.40
▸ LIMK1 P53667 1/20 0.39
▸ LIMK2 P53671 1/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16893143 0.91 MAPK1 (0.52) GSK3BNAMPTADORA1ADORA2AEPHX1
SCHEMBL16893017 0.91 ADORA1 (0.46) GSK3BNAMPTADORA1ADORA2AEPHX1
SCHEMBL16893034 0.88 ADORA1 (0.48) ADORA1ADORA2ANPSR1PTAFRMAPK1
SCHEMBL16893141 0.88 NAMPT (0.40) GSK3BNAMPTEPHX1PTAFRPTGFR
SCHEMBL16893116 0.85 NAMPT (0.38) GSK3BNAMPTEPHX1PTGFRMAPK1
SCHEMBL16893092 0.77 GSK3B (0.41) GSK3BNAMPTEPHX1PTAFRPTGFR
SCHEMBL16893064 0.75 MAPT (0.45) ADORA1ADORA2AMAPTNPSR1KMT2A
SCHEMBL16892977 0.74 AKT3 (0.46) GSK3B
SCHEMBL16893059 0.74 AURKA (0.38) ADORA1ADORA2AEPHX1MAPK1KMT2A
SCHEMBL16892989 0.74 MAPK1 (0.40) GSK3BADORA1ADORA2AEPHX1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363906-B1 HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF VERTEX PHARMA (US) 2015-07-15 — — EP claimed
Send feedback